T1	Participants 325 406	11 patients and 5 volunteers and 750 mg was given to 16 patients and 5 volunteers
T2	Participants 460 595	cured patients taking 750 mg mefloquine, peak plasma drug concentration (Cmax) and area under the plasma concentration-time curve (AUC)
T3	Participants 635 725	patients for whom treatment failed (p less than 0.0005 and p less than 0.01, respectively)
